Final week, the Federal Commerce Fee (FTC) launched a report titled “Pharmacy Profit Managers: The Highly effective Middlemen Inflating Drug Prices and Squeezing Fundamental Road Pharmacies.” Whereas I received’t get into an evaluation of the particular arguments FTC made, the report does have various fascinating statistics and graphics on pharmacy profit managers (PBMs). Some highlights are under.
First, PBMs do rather more than simply design formularies. Now they’re extremely built-in entities, with many giant PBMs being owned immediately by well being plans.
PBM measurement elevated resulting from a sequence of consolidations over the previous 25 years.
The market share of the three largest PBMs (CVS Caremark, Specific Scripts (ESI), and OptumRx) elevated from 70% to 79% of the PBM market.
Specialty mail order pharmacy is growing as a share or PBM income relative to different channels.
Actually, PBM mother or father corporations’ income comprised 22% of all US nationwide well being expenditure as of 2023.
You’ll be able to learn the total report right here.
